Venus Remedies Limited’s R3SET division embarks on wellness journey with expanded offerings
Venus Remedies Limited, a leader in pharmaceutical research and development, has announced a major transformation of its consumer healthcare division, R3SET. This strategic pivot marks ... Read More
Venus Remedies expands global reach with market authorizations in Saudi Arabia and Philippines
Venus Remedies Limited, a prominent player in the global pharmaceutical industry, announced its latest achievement of receiving marketing authorizations for critical healthcare products in Saudi ... Read More
Venus Remedies expands globally with Elores launch in Ecuador: Tackling multi-drug-resistant infections
Venus Remedies Limited, renowned for healthcare innovation, continues its global growth trajectory with the latest launch of its cutting-edge antibiotic formulation, Elores, in Ecuador. Building ... Read More
Venus Remedies expands cancer drug portfolio in South Eastern Europe
In a significant development for its oncology portfolio in South Eastern Europe, Venus Remedies Ltd has been granted marketing authorization from Serbia for chemotherapy drugs ... Read More
Venus Remedies secures marketing authorization for Meropenem in Spain
Venus Remedies has made a significant stride by securing marketing authorization from Spain for its top-selling generic product, meropenem. The Indian pharmaceutical company obtained this ... Read More
Venus Remedies gets GMP certification from Ukraine for Carbapenem, oncology parenteral plants
Venus Remedies, an Indian pharmaceutical company, has secured Good Manufacturing Practices (GMP) certification from Ukraine for the production facilities of some of its pharmaceutical products. ... Read More
Venus Remedies forays into consumer healthcare market with R3SET Life
Venus Remedies, a Chandigarh-based pharma company, has forayed into the Indian consumer healthcare market, with the launch of R3SET, a holistic pain management solution. According ... Read More